Evidence map›Paper›PMID 36133811›Full record

ReviewFrontiers in pharmacology2022

Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations.

Çiğdem Yücel, Gökçe Şeker Karatoprak, Özlem Bahadır Açıkara, Esra Küpeli Akkol, Timur Hakan Barak, Eduardo Sobarzo-Sánchez, Michael Aschner, Samira Shirooie

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Ethnobotany-guided exploration of plant-derived photosensitizer candidates for photodynamic therapy.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Çiğdem YücelDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
Gökçe Şeker KaratoprakDepartment of Pharmacognosy, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
Özlem Bahadır AçıkaraDepartment of Pharmacognosy, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Esra Küpeli AkkolDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
Timur Hakan BarakDepartment of Pharmacognosy, Faculty of Pharmacy, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
Eduardo Sobarzo-SánchezDepartment of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Park Avenue Bronx, NY, United States.
Samira ShirooiePharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Erciyes University · TRAcıbadem Adana Hospital · TRAlbert Einstein College of Medicine · USAnkara University · TRGazi University · TRKermanshah University of Medical Sciences · IRUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginger (

Indexed as

cytokinegingergingerolimmunomodulatoryZingiber officinale

Identifiers

PMID36133811
PMCPMC9483099
OpenAlexW4294629135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.